Atazanavir Sulfate
- Product NDC
- 16714-862
- 11-digit product format
- 167140862
- Labeler code
- 16714
- Product ID
- 16714-862_c5ff6121-ec6c-49b4-a722-81feecbb0bb5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atazanavir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NorthStar Rx LLC
- Application
- ANDA204806
- Marketing category
- ANDA
- Marketing start
- 2019-04-08
- Marketing end
- 0000-00-00
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-862-01 | 16714086201 | 30 CAPSULE in 1 BOTTLE (16714-862-01) | 30 capsule | 2019-04-08 | 0000-00-00 | No | No | Current |